Pfizer to Boost Pipeline With US$ 5,4 Billion Global Blood Therapeutics Buy

Sumber: Reuters | Editor: Anastasia Lilin Yuliantina

KONTAN.CO.ID - Pfizer Inc will buy blood disorder drugmaker Global Blood Therapeutics in a US$ 5,4 billion deal, as it looks to boost its pipeline to combat a potential slowdown in Covid product demand that analysts anticipate from falling cases.

New York-based Pfizer, flush with cash from sales of its Covid-19 vaccine last year, has been on the lookout for acquisitions that could bring in billions in annual sales by the end of the decade.